2024 annual financial data
Rein Therapeutics 2024 Operating margin
Rein Therapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -65,112,000 USD and net income was -62,883,000 USD.
Operating cash flow was -22,291,000 USD.
Get free Rein Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -65,112,000 USD
- Net income
- -62,883,000 USD
- Operating cash flow
- -22,291,000 USD